The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pet Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
The global Pet Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pet Vaccine in various end use industries. The expanding demands from the Canine, Avian and Feline,, are propelling Pet Vaccine market. Attenuated Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Conjugate Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Pet Vaccine market, driven by demand from China, the second largest economy with some signs of stabilising, the Pet Vaccine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pet Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pet Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pet Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pet Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pet Vaccine covered in this report include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc.
The global Pet Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Global Pet Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Vaccine market, Segment by Type:
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Global Pet Vaccine market, by Application
Canine
Avian
Feline
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Pet Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pet Vaccine in various end use industries. The expanding demands from the Canine, Avian and Feline,, are propelling Pet Vaccine market. Attenuated Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Conjugate Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Pet Vaccine market, driven by demand from China, the second largest economy with some signs of stabilising, the Pet Vaccine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pet Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pet Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pet Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pet Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pet Vaccine covered in this report include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc.
The global Pet Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Global Pet Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Vaccine market, Segment by Type:
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Global Pet Vaccine market, by Application
Canine
Avian
Feline
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pet Vaccine Market Overview
1.1 Pet Vaccine Product Overview
1.2 Pet Vaccine Market Segment by Type
1.2.1 Attenuated Live Vaccines
1.2.2 Conjugate Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Toxoid Vaccines
1.2.6 DNA Vaccines
1.2.7 Recombinant Vaccines
1.3 Global Pet Vaccine Market Size by Type
1.3.1 Global Pet Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Pet Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pet Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pet Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pet Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pet Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pet Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pet Vaccine Sales Breakdown by Type (2018-2023)
2 Global Pet Vaccine Market Competition by Company
2.1 Global Top Players by Pet Vaccine Sales (2018-2023)
2.2 Global Top Players by Pet Vaccine Revenue (2018-2023)
2.3 Global Top Players by Pet Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Pet Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pet Vaccine Market Competitive Situation and Trends
2.5.1 Pet Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pet Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Pet Vaccine Market
2.8 Key Manufacturers Pet Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pet Vaccine Status and Outlook by Region
3.1 Global Pet Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pet Vaccine Historic Market Size by Region
3.2.1 Global Pet Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Pet Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Pet Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pet Vaccine Forecasted Market Size by Region
3.3.1 Global Pet Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Pet Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Pet Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pet Vaccine by Application
4.1 Pet Vaccine Market Segment by Application
4.1.1 Canine
4.1.2 Avian
4.1.3 Feline
4.2 Global Pet Vaccine Market Size by Application
4.2.1 Global Pet Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Pet Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pet Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pet Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pet Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pet Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pet Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pet Vaccine Sales Breakdown by Application (2018-2023)
5 North America Pet Vaccine by Country
5.1 North America Pet Vaccine Historic Market Size by Country
5.1.1 North America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pet Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Pet Vaccine Sales in Value by Country (2018-2023)
5.2 North America Pet Vaccine Forecasted Market Size by Country
5.2.1 North America Pet Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Pet Vaccine Sales in Value by Country (2024-2029)
6 Europe Pet Vaccine by Country
6.1 Europe Pet Vaccine Historic Market Size by Country
6.1.1 Europe Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pet Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Pet Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Pet Vaccine Forecasted Market Size by Country
6.2.1 Europe Pet Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Pet Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Pet Vaccine by Region
7.1 Asia-Pacific Pet Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Pet Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pet Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pet Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pet Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Pet Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pet Vaccine Sales in Value by Region (2024-2029)
8 Latin America Pet Vaccine by Country
8.1 Latin America Pet Vaccine Historic Market Size by Country
8.1.1 Latin America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pet Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pet Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Pet Vaccine Forecasted Market Size by Country
8.2.1 Latin America Pet Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pet Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Pet Vaccine by Country
9.1 Middle East and Africa Pet Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pet Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pet Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pet Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Pet Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pet Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Company Information
10.1.2 Bayer Healthcare Introduction and Business Overview
10.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Healthcare Pet Vaccine Products Offered
10.1.5 Bayer Healthcare Recent Development
10.2 Vetoquinol S.A
10.2.1 Vetoquinol S.A Company Information
10.2.2 Vetoquinol S.A Introduction and Business Overview
10.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Vetoquinol S.A Pet Vaccine Products Offered
10.2.5 Vetoquinol S.A Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Pet Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Introduction and Business Overview
10.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ceva Pet Vaccine Products Offered
10.4.5 Ceva Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly Pet Vaccine Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Heska Co.
10.6.1 Heska Co. Company Information
10.6.2 Heska Co. Introduction and Business Overview
10.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Heska Co. Pet Vaccine Products Offered
10.6.5 Heska Co. Recent Development
10.7 Merck Animal Health
10.7.1 Merck Animal Health Company Information
10.7.2 Merck Animal Health Introduction and Business Overview
10.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Animal Health Pet Vaccine Products Offered
10.7.5 Merck Animal Health Recent Development
10.8 Merial (Sanofi)
10.8.1 Merial (Sanofi) Company Information
10.8.2 Merial (Sanofi) Introduction and Business Overview
10.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Merial (Sanofi) Pet Vaccine Products Offered
10.8.5 Merial (Sanofi) Recent Development
10.9 Virbac
10.9.1 Virbac Company Information
10.9.2 Virbac Introduction and Business Overview
10.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Virbac Pet Vaccine Products Offered
10.9.5 Virbac Recent Development
10.10 Zoetis (Pfizer)
10.10.1 Zoetis (Pfizer) Company Information
10.10.2 Zoetis (Pfizer) Introduction and Business Overview
10.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered
10.10.5 Zoetis (Pfizer) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pet Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pet Vaccine Industrial Chain Analysis
11.4 Pet Vaccine Market Dynamics
11.4.1 Pet Vaccine Industry Trends
11.4.2 Pet Vaccine Market Drivers
11.4.3 Pet Vaccine Market Challenges
11.4.4 Pet Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pet Vaccine Distributors
12.3 Pet Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
